Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationJan Moritz Middeke, Johannes Schetelig, Min Fang et al.|Blood|2014Cited by 74
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligenceJan‐Niklas Eckardt, Jan Moritz Middeke, Waldemar Hahn et al.|npj Digital Medicine|2024Cited by 58
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestationsJan‐Niklas Eckardt, Jan Moritz Middeke, Friedrich Stölzel et al.|Journal of Hematology & Oncology|2022Cited by 58
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trialAnna‐Katharina Zoellner, Eva Hoster, Kai Hübel et al.|The Lancet Haematology|2021Cited by 53
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan‐Niklas Eckardt, Jan Moritz Middeke, Christoph Röllig et al.|Haematologica|2022Cited by 47